← SynDRA
ASTX-660
SynDRA canonical compound SYN0039313 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | BIRC2 | XIAP |
|---|
| Mechanism of action | apoptosis inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- apoptosis inhibitor
- XIAP INHIBITOR
Cross-references
Synonyms
- Tolinapant
- ASTX660
- YCXOHEXZVKOGEV-DNRQZRRGSA-N
- SCHEMBL16830758
- CS-8216
- HY-109565
- 1-(6-(4-fluorobenzyl)-5-(hydroxymethyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-((2R,5R)-5-methyl-2-(((R)-3-methylmorpholino)methyl)piperazin-1-yl)ethan-1-one
- ASTX 660
- 2LHZ9ZC3YO
- RefChem:115371
- XIAP/cIAP1 Antagonist ASTX660
- ASTX 660 [WHO-DD]
- MFCD31619274
- ASTX660(Tolinapant?
- TOLINAPANT [INN]
- UNII-2LHZ9ZC3YO
- orb1296257
- SCHEMBL29441233
- C30H42FN5O3
- GTPL12704
- TQP0801
- EX-A2904
- BDBM50450046
- NSC804861
- EBC-312051
- NSC-804861
- compound 27 [PMID: 30091600]
- AC-36446
- BA166845
- BP-42842
- MS-29955
- G16213
- A744789
- Z3325731321
- T202128
- 8A5HG6UTT6
- UNII-8A5HG6UTT6
- Tolinapant dihydrochloride
- SCHEMBL16830776
Look up ASTX-660 in the interactive SynDRA portal →